Nel ASA Faces Twin Deadlines: A Vacant Corner Office and an October Scorecard

Nel ASA's stock hovers near lows amid CEO search and upcoming Q3 results, with leadership and operational clarity expected by late 2026.

Investors in the Norwegian electrolyser maker are staring at two distinct dates on the calendar, each carrying its own weight. The first arrives in mid-December, when Håkon Volldal's six-month notice period formally expires. The second lands sooner — 21 October 2026 — when Nel ASA is scheduled to publish its third-quarter results, followed by the fourth-quarter report on 18 February 2027.

Neither date offers certainty. Together, they frame a period of acute suspense for a company whose share price has already absorbed a heavy toll.

The stock last changed hands at roughly EUR 0.19, a decline of about 48 percent from the 52-week high of EUR 0.3655 reached in May. It sits barely 10 percent above the February trough of EUR 0.1731. Technical indicators paint a cautious picture: the shares trade beneath their 50-day moving average of approximately EUR 0.20, while the relative strength index hovers near 38 — a reading that suggests room for a bounce, but little in the way of momentum.

Leadership Vacuum Meets Operational Scrutiny

The search for Volldal's successor has yet to yield a confirmed name, leaving the company's strategic direction — capital allocation, cost-cutting pace, investor communication — in a state of suspended animation. Whoever takes the helm will inherit an industry still struggling with thin margins and patchy demand for green hydrogen, a sector-wide backdrop that has dampened appetite for new capital commitments.

The market has had weeks to digest the absence of fresh catalysts. No major orders have been announced, no analyst actions have shifted the narrative, and no regulatory developments have offered a spark. What remains is a stock caught between a leadership question mark and an operational scorecard that has disappointed before.

The Bullish Case: Clarity as a Catalyst

Optimists see two potential triggers. A decisive appointment — a successor with a credible growth-and-cost agenda — could signal continuity and strategic purpose, potentially steadying investor confidence that has eroded over successive quarters. The technical setup supports the argument: with the RSI below 40, the stock is not overbought, and a positive surprise could generate the kind of move that technical traders feed on.

The October report offers a second avenue for relief. Should Nel demonstrate that order intake is stabilising or recovering, and that cost discipline is yielding visible results, the narrative could shift from perpetual loss-maker to a company emerging from the trough. In an electrolyser business that lives and dies by industrial-scale hydrogen projects, any sign of momentum in the pipeline would carry outsized significance.

The Bearish Case: Paralysis by Default

The risks are equally concrete. Should December arrive with the CEO chair still empty, or should the board settle on an interim arrangement lacking strategic conviction, the company risks drifting into a leadership vacuum at precisely the wrong moment. A successor perceived as a compromise pick could further dent confidence rather than restore it.

The October numbers carry their own hazards. If the third-quarter report extends the pattern of disappointing order intake and persistent cost pressure, the downward drift could accelerate. Analysts remain cautious — JPMorgan cut its price target to NOK 1.80 from NOK 2.90 in early August while maintaining a "Neutral" stance, a move that underscored the prevailing scepticism even if it no longer reflects the most current view.

Structural headwinds compound the company-specific concerns. Delays in subsidy programmes or a slower-than-expected build-out of green hydrogen infrastructure could keep squeezing visibility on new orders, regardless of what Nel does internally.

A Shared Point of Tension

What unites both scenarios is the recognition that Nel's near-term fate hinges on information that has yet to materialise. The leadership question and the operational question are intertwined: a new CEO announced before the October report could shape how those numbers are interpreted, while a strong third-quarter showing could buy the board time and credibility in its search.

Until one of those variables resolves, the shares look likely to remain confined to their recent trading range — lacking a catalyst for recovery, but equally lacking an acute new source of pressure. The window for change opens on 21 October, when the company either demonstrates that its operational slide has halted or confirms that the wait for better news continues. December's deadline for the leadership question ensures that, one way or another, the uncertainty gripping the stock cannot persist indefinitely.